
Phase 2a Study Assessing Colonization Efficiency, Safety, and Acceptability of Lactobacillus crispatus CTV-05 in Women With Bacterial Vaginosis
Author(s) -
Anke Hemmerling,
W. G. Harrison,
Adrienne Schroeder,
Jeanna Park,
Abner P. Korn,
Stephen Shiboski,
Anne Foster-Rosales,
Craig R. Cohen
Publication year - 2010
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0b013e3181e50026
Subject(s) - medicine , bacterial vaginosis , placebo , tolerability , dysuria , lactobacillus crispatus , vaginal flora , adverse effect , vagina , lactobacillus , genitourinary system , vaginal disease , randomized controlled trial , gynecology , urinary system , surgery , alternative medicine , pathology , biology , bacteria , genetics
Bacterial vaginosis (BV) is a common vaginal infection caused by a lack of endogenous lactobacilli and overgrowth of pathogens that frequently recurs following antibiotic treatment.